These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 10550417

  • 1. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus.
    Moriwaki M, Itoh N, Miyagawa J, Yamamoto K, Imagawa A, Yamagata K, Iwahashi H, Nakajima H, Namba M, Nagata S, Hanafusa T, Matsuzawa Y.
    Diabetologia; 1999 Nov; 42(11):1332-40. PubMed ID: 10550417
    [Abstract] [Full Text] [Related]

  • 2. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT, Morgan DJ, Krahl T, Ko A, Sarvetnick N, Sherman LA.
    J Immunol; 1999 Oct 15; 163(8):4335-41. PubMed ID: 10510373
    [Abstract] [Full Text] [Related]

  • 3. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.
    Thomas HE, Darwiche R, Corbett JA, Kay TW.
    J Immunol; 1999 Aug 01; 163(3):1562-9. PubMed ID: 10415060
    [Abstract] [Full Text] [Related]

  • 4. Fas ligand down-regulates cytokine-induced Fas receptor expression on insulinoma (NIT-1), but not islet cells, from autoimmune nonobese diabetic mice.
    Augstein P, Heinke P, Salzsieder E, Berg S, Rettig R, Salzsieder C, Harrison LC.
    Endocrinology; 2004 Jun 01; 145(6):2747-52. PubMed ID: 15033908
    [Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms of pancreatic beta-cell destruction in autoimmune diabetes: potential targets for preventive therapy.
    Iwahashi H, Itoh N, Yamagata K, Imagawa A, Nakajima H, Tomita K, Moriwaki M, Waguri M, Yamamoto K, Miyagawa J, Namba M, Hanafusa T, Matsuzawa Y.
    Cytokines Cell Mol Ther; 1998 Mar 01; 4(1):45-51. PubMed ID: 9557216
    [Abstract] [Full Text] [Related]

  • 6. In vivo blockade of the Fas-Fas ligand pathway inhibits cyclophosphamide-induced diabetes in NOD mice.
    Mahiou J, Walter U, Lepault F, Godeau F, Bach JF, Chatenoud L.
    J Autoimmun; 2001 Jun 01; 16(4):431-40. PubMed ID: 11437491
    [Abstract] [Full Text] [Related]

  • 7. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
    Redd S, Ginn S, Ross JM.
    Histochem J; 2002 Jun 01; 34(1-2):1-12. PubMed ID: 12365794
    [Abstract] [Full Text] [Related]

  • 8. Role of Fas-FasL in insulitis in nonobese diabetic mouse.
    Cao JY, Wang H.
    Chin Med J (Engl); 2004 Apr 01; 117(4):615-7. PubMed ID: 15109461
    [No Abstract] [Full Text] [Related]

  • 9. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas.
    Augstein P, Bahr J, Wachlin G, Heinke P, Berg S, Salzsieder E, Harrison LC.
    J Autoimmun; 2004 Dec 01; 23(4):301-9. PubMed ID: 15571924
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Death effectors of beta-cell apoptosis in type 1 diabetes.
    Lee MS, Chang I, Kim S.
    Mol Genet Metab; 2004 Dec 01; 83(1-2):82-92. PubMed ID: 15464423
    [Abstract] [Full Text] [Related]

  • 16. Fas ligand-mediated mechanisms are involved in autoimmune destruction of islet beta cells in non-obese diabetic mice.
    Suarez-Pinzon WL, Power RF, Rabinovitch A.
    Diabetologia; 2000 Sep 01; 43(9):1149-56. PubMed ID: 11043861
    [Abstract] [Full Text] [Related]

  • 17. CMV-hFasL transgenic mice are sensitive to low doses of streptozotocin-induced type I diabetes mellitus.
    Lin B, Zhang ZL, Yu LY, Guo LH.
    Acta Pharmacol Sin; 2003 Dec 01; 24(12):1199-204. PubMed ID: 14653944
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.